Global Burden of Hepatoblastoma From 1990 to 2021 and Projection to 2030

Global Burden of Hepatoblastoma From 1990 to 2021 and Projection to 2030

ABSTRACT Background Hepatoblastoma (HB) is the most common primary pediatric hepatocellular carcinoma, and the five‐year survival rate for HB is the lowest among childhood cancers, as 20% of cases are chemotherapy resistant or unresectable. Understanding the global burden of HB and future trends in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaoyu Huang, Zhiqiang Zhang, Qiong Wu, Shaoyang Kang, Xinyue Yang, Fengmei Wang
Format:	Article
Language:	English
Published:	Wiley 2025-08-01
Series:	Cancer Medicine
Subjects:	Bayesian age‐period‐cohort modeling global burden hepatoblastoma pediatric population prediction
Online Access:	https://doi.org/10.1002/cam4.71163
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Global, regional and national disease burden of food-borne trematodiases: projections to 2030 based on the Global Burden of Disease Study 2021
by: Lu Liu, et al.
Published: (2024-12-01)

Global, regional, and national burden of malaria, 1990–2021: Findings from the global burden of disease study 2021
by: Shun-Xian Zhang, et al.
Published: (2024-01-01)

Global, regional, and national burden of ovarian cancer in women aged 45 + from 1990 to 2021 and projections for 2050: a systematic analysis based on the 2021 global burden of disease study
by: Yanan Ren, et al.
Published: (2025-08-01)

Malignant hypertension secondary to renin-producing hepatoblastoma
by: Doinita Sfrijan, et al.
Published: (2020-01-01)

Burden of Carbon Monoxide Poisoning in Asian Countries From 1990 to 2021 and Its Projection Until 2030: An Analysis of the Global Burden of Disease Study 2021
by: Xie J, et al.
Published: (2025-04-01)

The importance of age as a prognostic predictor of childhood hepatoblastoma: an analysis of single-center childhood hepatoblastoma in China
by: Zhen Li, et al.
Published: (2025-03-01)

Long-term trends and future projections of liver cancer burden in China from 1990 to 2030
by: Zhouwei Zhan, et al.
Published: (2025-04-01)

Global, regional, and national burden of musculoskeletal disorders, 1990–2021: an analysis of the global burden of disease study 2021 and forecast to 2035
by: Meizhi Liu, et al.
Published: (2025-08-01)

Global burden of childhood developmental intellectual disability caused by iodine deficiency from 1990 to 2021 and projection to 2040
by: Zihao Liu, et al.
Published: (2025-07-01)

Trends in stroke incidence and mortality in China, Japan, and South Korea (1990–2021) with projections to 2035
by: Liyuan Yang, et al.
Published: (2025-07-01)

Down syndrome burden in China and globally: a comparative analysis of 1990–2021 trends and future projections based on GBD 2021 database
by: Xiangwen Tu, et al.
Published: (2025-08-01)

Smoking-related bladder cancer burden from 1990 to 2021: An age-period-cohort analysis of the global burden of disease study
by: Qingqing Yu, et al.
Published: (2025-06-01)

Hepatoblastoma regional trends: dynamic SDI & joinpoint regression analysis
by: Miao Jia, et al.
Published: (2025-07-01)

Burdens of sense organ diseases across global, regional, and national levels from 1990 to 2021 and projections for 2050
by: Min-Jun Zhao, et al.
Published: (2025-08-01)

Burden of kidney cancer in China from 1990 to 2021 and predictions for 2036: an age-period-cohort analysis of global burden of disease study 2021
by: Yi-Fan Zhang, et al.
Published: (2025-07-01)

Comparison of ultrasonographic features between two types of hepatic echinococcosis and hepatoblastoma in children
by: Yi Tao, et al.
Published: (2025-01-01)

Global burden and cross-country inequalities in gallbladder and biliary tract cancer (1990–2021) with projections to 2050: insights from the global burden of disease study 2021
by: Diya Xie, et al.
Published: (2025-05-01)

Multidisciplinary Management of Hepatoblastoma: Three Years of Experience at a Single Centre
by: Esra Arslantaş, et al.
Published: (2024-08-01)

Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
by: Wei-Yun Hsu, et al.
Published: (2020-08-01)

Validation of the stratification for newly diagnosed hepatoblastoma: An analysis from the Children’s Hepatic tumors International Collaboration (CHIC) database
by: Arun A. Rangaswami, et al.
Published: (2025-06-01)

Time trend of measles burden on children and adolescents in BRICS-plus countries from 1990 to 2021 and prediction to 2032
by: Hongxia Yuan, et al.
Published: (2025-07-01)

Burden, trends, and predictions of low physical activity-related diseases in China: analysis from the Global Burden of Disease Study, 1990–2021, with projections to 2035
by: Chuan Zhang, et al.
Published: (2025-02-01)

The burden of polycystic ovary syndrome-related infertility in 204 countries and territories, 1990-2021: an analysis of the global burden of disease study 2021
by: Lan Zheng, et al.
Published: (2025-06-01)

Trends and projections of the burden of disease for male infertility in China from 1990 to 2021: an analysis from the Global Burden of Disease 2021 study
by: Ran Xu, et al.
Published: (2024-12-01)

Insights into the mechanisms of angiogenesis in hepatoblastoma
by: Meng Kong, et al.
Published: (2025-05-01)

Burdens of Breast Cancer and Projections for 2030 Among Women in Asia: Findings from the 2021 Global Burden of Disease Study
by: Feng Wang, et al.
Published: (2025-05-01)

Trends and cross-country inequality in the global burden of nutritional deficiencies in children, with projections to 2035: results from the Global Burden of Disease study 2021
by: Shihao Zhuang, et al.
Published: (2025-07-01)

Global burden of asthma attributable to high body mass index in older adults 1990–2021 and prediction to 2050: An analysis of Global Burden of Disease Study 2021
by: Zhikang Wang, MPH, et al.
Published: (2025-03-01)

Global disease burden analysis of Cardiometabolic disease attributable to second-hand smoke exposure from 1990 to 2040
by: Yan Liu, et al.
Published: (2025-03-01)

Neutrophil-induced pyroptosis promotes survival in patients with hepatoblastoma
by: Tingyi Fu, et al.
Published: (2025-02-01)

Trends in the global, regional, and national burden of cardiovascular diseases attributed to high systolic blood pressure from 1990 to 2021 and projections to 2045: a systematic analysis based on GBD 2021 data
by: Tenglong Hu, et al.
Published: (2025-05-01)

Global, regional, and national burden of cutaneous malignant melanoma from 1990 to 2021 and prediction to 2045
by: Chengling Liu, et al.
Published: (2024-12-01)

Global, regional, and national burden of gastroesophageal reflux disease (1990–2021): age-period-cohort analysis and Bayesian projections
by: Liumei Mo, et al.
Published: (2025-07-01)

Anticancer activity of sulforaphane against human hepatoblastoma cells involves apoptosis, autophagy and inhibition of β-catenin signaling pathway
by: Junshan Lin, et al.
Published: (2020-06-01)

The burden of attention deficit hyperactivity disorder and incidence rate forecast in China from 1990 to 2021
by: Ningyu Li, et al.
Published: (2025-03-01)

Osteoarthritis burden and inequality from 1990 to 2021: a systematic analysis for the global burden of disease Study 2021
by: Ruofeng Wu, et al.
Published: (2025-03-01)

Analysis and comparison of the trends in burden of intracerebral hemorrhage in China from 1990 to 2021: results from the 2021 Global Burden of Disease Study
by: Shuai Han, et al.
Published: (2025-08-01)

Temporal and spatial trends in gastric cancer burden in the USA from 1990 to 2021: findings from the global burden of disease study 2021
by: Chengwei Zhan, et al.
Published: (2024-12-01)

Global, regional, and national larynx cancer burden and health inequality analysis from 1990 to 2021 with a prediction from 2022 to 2040
by: Junjie Jiang, et al.
Published: (2025-07-01)

Balanced care in managing hepatoblastoma in a patient with trisomy 18: A case report
by: Lori-Anne Lajeunesse, et al.
Published: (2025-01-01)